Growth Metrics

Aligos Therapeutics (ALGS) Amortizatization of Intangibles (2021 - 2025)

Aligos Therapeutics filings provide 5 years of Amortizatization of Intangibles readings, the most recent being $805000.0 for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 116.4% to $805000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 million, a 22.71% increase, with the full-year FY2025 number at $2.2 million, up 22.71% from a year prior.
  • Amortizatization of Intangibles hit $805000.0 in Q4 2025 for Aligos Therapeutics, up from $349000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $822000.0 in Q4 2021 to a low of -$542000.0 in Q3 2022.
  • Median Amortizatization of Intangibles over the past 5 years was $332500.0 (2025), compared with a mean of $319950.0.
  • Biggest five-year swings in Amortizatization of Intangibles: tumbled 27000.0% in 2022 and later surged 3066.67% in 2023.
  • Aligos Therapeutics' Amortizatization of Intangibles stood at $822000.0 in 2021, then tumbled by 90.88% to $75000.0 in 2022, then skyrocketed by 408.0% to $381000.0 in 2023, then fell by 2.36% to $372000.0 in 2024, then soared by 116.4% to $805000.0 in 2025.
  • The last three reported values for Amortizatization of Intangibles were $805000.0 (Q4 2025), $349000.0 (Q3 2025), and $718000.0 (Q2 2025) per Business Quant data.